相关实验视频

Updated: May 28, 2025

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

针对HER2的疗法:揭开它们在胆道癌症中的作用

Charalampos Theocharopoulos¹, Ioannis A Ziogas², Benedetto Mungo²

¹Department of Surgery, Metaxa Cancer Hospital, Piraeus 18537, Greece.

Critical reviews in oncology/hematology

|February 9, 2025

概括

向人类表皮生长因子受体2 (HER2) 在胆道癌症 (BTCs) 方面表现有前途. 针对HER2的疗法正在成为高级BTC的有效治疗方法,改善生存结果.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学遗传学是一个

背景情况:

胆道癌 (BTC) 的发病率正在上升,晚期预后不佳.
基因组分析揭示了可操作的目标,包括人类表皮生长因子受体2 (HER2).
在其他固体瘤中,HER2是经过验证的治疗标.

研究的目的:

审查在BTC中HER2导向剂的不断变化的景观.
总结关于BTC HER2向疗法的疗效和生存益处的证据.
讨论HER2改变在BTC中的作用及其治疗影响.

主要方法:

在BTC中对HER2导向药物的临床前和临床数据的审查.
分析最近的临床试验,调查针对HER2的治疗方法.
在BTC中检查HER2表达频率和预后意义.

主要成果:

HER2阳性高级BTCs显示了针对性治疗的改善结果,如trastuzumab组合.
含trastuzumab的疗法在一线治疗中显示出有前途的疗效.
特拉斯图祖马布德鲁克斯泰坎的瘤无关药的批准扩大了BTC的HER2导向选项.

结论:

针对HER2的药物代表了BTC治疗的重大进步.
针对HER2提供了一种有希望的策略,以提高高级BTC的生存率.
对HER2向疗法的进一步研究对于优化BTC管理至关重要.

关键词:

抗体与药物的结合物.胆道癌是一种胆道癌症.双特异性抗体双特异性抗体胆性瘤是一种胆性瘤.单克隆抗体是一种单克隆抗体.有针对性的治疗方法.

更多相关视频

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...